Suggested reference for usage, dosage and optimal taking time of Sotorasibu (AMG 510)

Sotoracib is an oral small molecule targeted drug mainly used to treat patients with KRAS G12C mutation-positive non-small cell lung cancer. Its mechanism of action is to selectively and irreversibly inhibit KRAS G12C mutant protein, thereby blocking abnormal signaling pathways and inhibiting tumor cell proliferation. As a targeted therapy drug, the usage and dosage of sotoraxib should strictly follow the instructions of doctors to ensure efficacy and safety.

The recommended standard dose is 960mg taken orally once daily (usually four 240mg tablets). During use, patients should maintain regular medication to ensure stable drug concentration in the body. If a patient experiences mild or moderate side effects, such as mild diarrhea, fatigue, or rash, doctors may make dose adjustments or short-term discontinuation based on the specific situation to maintain the continuity and safety of treatment.

The best time to take Sotorracib is usually recommended to be taken orally at a fixed time each day, and can be taken before or after a meal. Taking the medicine on an empty stomach may increase the risk of gastrointestinal discomfort for some patients. Therefore, they can choose to take it after meals according to their own tolerance to reduce gastrointestinal reactions such as nausea and diarrhea. At the same time, taking medication at the same time every day will help maintain stable blood concentration and improve efficacy.

In daily medication management, patients should avoid concurrent use with certain CYP3A4 strong inhibitors or inducers, so as not to affect the plasma concentration and efficacy of sotoraxib. If the dose needs to be adjusted or discontinued, this should be done under the guidance of a doctor. Regular follow-up and regular examination of blood, liver and kidney function and imaging indicators can help evaluate the efficacy and monitor side effects, thereby achieving safe and effective long-term targeted therapy.

Reference link:https://www.drugs.com